Dupont Capital Management’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-819
Closed -$232K 1779
2021
Q2
$232K Buy
+819
New +$222K 0.01% 1285
2019
Q4
Sell
-3,229
Closed -$335K 1271
2019
Q3
$335K Buy
3,229
+504
+18% +$54.2K 0.01% 953
2019
Q2
$350K Hold
2,725
0.01% 943
2019
Q1
$348K Hold
2,725
0.01% 897
2018
Q4
$341K Buy
2,725
+519
+24% +$88.8K 0.01% 872
2018
Q3
$489K Sell
2,206
-2,383
-52% -$483K 0.01% 722
2018
Q2
$735K Sell
4,589
-6,808
-60% -$870K 0.02% 623
2018
Q1
$1.06M Buy
+11,397
New +$852K 0.03% 498

Other funds holding MED

Dupont Capital Management's MED Position: Q3 2021 in Review

Dupont Capital Management sold out of Medifast (MED) in Q3 2021, closing a stake of 819 shares — an estimated $232K sold.

Dupont Capital Management first reported a position in MED in Q1 2018 and held it in 8 quarters. The position peaked at $1.06M in Q1 2018. 296 funds tracked by Wall St. Rank hold MED as of Q3 2021.

  • Dupont Capital Management reported no remaining Medifast position as of Q3 2021 after selling out during the quarter.
  • Dupont Capital Management sold 819 Medifast shares in Q3 2021, an estimated $232K.
  • Dupont Capital Management first reported a position in Medifast in Q1 2018 and held it in 8 quarters.
  • Dupont Capital Management's Medifast position peaked at $1.06M in Q1 2018.
  • 296 funds tracked by Wall St. Rank held Medifast as of Q3 2021.

Based on Dupont Capital Management's 13F filing for Q3 2021, filed 3 Nov 2021.